Published in Paediatr Perinat Epidemiol on January 01, 2005
Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ (2007) 1.94
Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003. Am J Epidemiol (2008) 1.06
Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study. BMC Pregnancy Childbirth (2011) 0.84
The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth (2006) 0.83
Maternal Smoking during Pregnancy and Daughters' Preeclampsia Risk. PLoS One (2015) 0.76
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol (2006) 6.69
The birth weight "paradox" uncovered? Am J Epidemiol (2006) 4.38
Association between swimming lessons and drowning in childhood: a case-control study. Arch Pediatr Adolesc Med (2009) 3.68
Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol (2010) 3.56
Illustrating bias due to conditioning on a collider. Int J Epidemiol (2009) 3.54
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39
Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27
BioCycle study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol (2009) 3.07
Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension (2007) 2.77
Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76
Quantification of collider-stratification bias and the birthweight paradox. Paediatr Perinat Epidemiol (2009) 2.68
Pathogenesis of preeclampsia. Annu Rev Pathol (2010) 2.66
Trends in smoking before, during, and after pregnancy--Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010. MMWR Surveill Summ (2013) 2.58
Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation (2011) 2.55
Designing prospective cohort studies for assessing reproductive and developmental toxicity during sensitive windows of human reproduction and development--the LIFE Study. Paediatr Perinat Epidemiol (2011) 2.50
Potential confounding by exposure history and prior outcomes: an example from perinatal epidemiology. Epidemiology (2007) 2.45
A comparison of LMP-based and ultrasound-based estimates of gestational age using linked California livebirth and prenatal screening records. Paediatr Perinat Epidemiol (2007) 2.26
The Youden Index and the optimal cut-point corrected for measurement error. Biom J (2005) 2.26
Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study. Am J Epidemiol (2008) 2.25
Infant morbidity and mortality attributable to prenatal smoking in the U.S. Am J Prev Med (2010) 2.18
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab (2004) 2.11
Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis (2010) 2.02
Stress reduces conception probabilities across the fertile window: evidence in support of relaxation. Fertil Steril (2010) 2.02
Conditioning on intermediates in perinatal epidemiology. Epidemiology (2012) 2.00
Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J (2008) 1.95
Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol (2003) 1.91
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation (2012) 1.88
Is it time for a meta-analysis? Hum Reprod Update (2008) 1.79
Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res (2007) 1.78
ROC curve analysis for biomarkers based on pooled assessments. Stat Med (2003) 1.75
Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr (2009) 1.69
An information criterion for marginal structural models. Stat Med (2012) 1.65
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63
Linear regression with an independent variable subject to a detection limit. Epidemiology (2010) 1.61
Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ (2009) 1.59
Pooling biospecimens and limits of detection: effects on ROC curve analysis. Biostatistics (2006) 1.58
Toxic trace metals and human oocytes during in vitro fertilization (IVF). Reprod Toxicol (2010) 1.57
Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. Fertil Steril (2007) 1.55
Participation of next of kin in research following sudden, unexpected death of a child. Arch Pediatr Adolesc Med (2007) 1.54
A time and place for causal inference methods in perinatal and paediatric epidemiology. Paediatr Perinat Epidemiol (2013) 1.51
Will decreasing assisted reproduction technology costs improve utilization and outcomes among minority women? Fertil Steril (2010) 1.51
Analysis of repeated pregnancy outcomes. Stat Methods Med Res (2006) 1.48
Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol (2003) 1.48
"Toward a clearer definition of confounding" revisited with directed acyclic graphs. Am J Epidemiol (2012) 1.48
Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol (2008) 1.47
Time at risk and intention-to-treat analyses: parallels and implications for inference. Epidemiology (2015) 1.47
Receiver operating characteristic curve inference from a sample with a limit of detection. Am J Epidemiol (2006) 1.46
Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect (2012) 1.44
Effect of dietary fiber intake on lipoprotein cholesterol levels independent of estradiol in healthy premenopausal women. Am J Epidemiol (2010) 1.44
Relative concentrations of organochlorines in adipose tissue and serum among reproductive age women. Environ Toxicol Pharmacol (2005) 1.42
Smoking patterns and use of cessation interventions during pregnancy. Am J Prev Med (2008) 1.40
Trying to avoid bias in case-control and case-cohort studies. Fertil Steril (2003) 1.40
Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait. Obstet Gynecol (2016) 1.40
Estimating the odds ratio when exposure has a limit of detection. Int J Epidemiol (2009) 1.39
Maximum likelihood ratio tests for comparing the discriminatory ability of biomarkers subject to limit of detection. Biometrics (2007) 1.35
On linear combinations of biomarkers to improve diagnostic accuracy. Stat Med (2005) 1.34
Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) (2007) 1.34
Weight-management interventions for pregnant or postpartum women. Am J Prev Med (2008) 1.32
Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures. Stat Med (2008) 1.31
From causal diagrams to birth weight-specific curves of infant mortality. Eur J Epidemiol (2008) 1.30
Heavy metals and couple fecundity, the LIFE Study. Chemosphere (2012) 1.30
Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab (2010) 1.30
Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol (2006) 1.28
Invited commentary: composite outcomes as an attempt to escape from selection bias and related paradoxes. Am J Epidemiol (2013) 1.27
Reduced bone cortical thickness in boys with autism or autism spectrum disorder. J Autism Dev Disord (2008) 1.26
Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol (2004) 1.25
Time-modified confounding. Am J Epidemiol (2009) 1.24
Estimates of smoking before and during pregnancy, and smoking cessation during pregnancy: comparing two population-based data sources. Public Health Rep (2013) 1.22
Maternal serum polychlorinated biphenyl concentrations across critical windows of human development. Environ Health Perspect (2007) 1.20
Circulating chemokine levels and miscarriage. Am J Epidemiol (2007) 1.19
Effects of different data-editing methods on trends in race-specific preterm delivery rates, United States, 1990-2002. Paediatr Perinat Epidemiol (2007) 1.17
Efficient design and analysis of biospecimens with measurements subject to detection limit. Biom J (2006) 1.17
A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab (2010) 1.16
Circulating angiogenic factors and placental abruption. Obstet Gynecol (2006) 1.15
Sperm chromatin structure assay as an independent predictor of fertility in vivo: a case-control study. Int J Androl (2009) 1.14
Reliability of maternal recall and reporting of child births and deaths in rural Egypt. Paediatr Perinat Epidemiol (2003) 1.13
Chronic diseases and related risk factors among low-income mothers. Matern Child Health J (2012) 1.13
Pooling designs for outcomes under a Gaussian random effects model. Biometrics (2011) 1.12
Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review. Am J Epidemiol (2013) 1.11
Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers (2008) 1.08
Age at menarche and metabolic markers for type 2 diabetes in premenopausal women: the BioCycle Study. J Clin Endocrinol Metab (2011) 1.08